Neurophysiologic Abnormality
9
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Development of Motility and Cognition in Infants
Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )
Investigation The Effect of Conventional Vs. Individualized tDCS Intensity to Achieve Uniform E-Fields
Efficacy of Laser Acupuncture on Neurophysiological Parameters of Median Nerve in Postpartum Women
Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients
Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
EXPRE-SON-REA : Expressive Own Names in Neurophysiologic Assessment of Comatose Patients
Sensory Neuromodulation Protocol for the Treatment of Post-stroke Oropharyngeal Dysphagia.
Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.